Click a link below to view the mailing archive as if it had been sent to you.
| 2013-05-31 12:15 | | Orphan Drug Status for Astellas' Candidate and more... |
| 2013-05-31 00:15 | | DoctorâÔö£é?öé??Ôö£é?ö?ñós Doubts Imperil Lucrative Diabetes Drugs and more... |
| 2013-05-30 12:15 | | GlaxoSmithKline has some good news, but no one seems to hear and more... |
| 2013-05-30 00:15 | | Bayer Shakes Up Prostate Cancer Market and more... |
| 2013-05-29 12:15 | | Are biotech IPOs already getting too hot to handle? and more... |
| 2013-05-29 00:15 | | As Forest CEO Plans Retirement, The Feds Issue A New Subpoena and more... |
| 2013-05-28 12:15 | | Valeant, Bausch & Lomb And The Long Reach Of Fred Hassan and more... |
| 2013-05-28 00:15 | | Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet |
| 2013-05-27 12:15 | | Booming Irish pharmaceutical sector sets sights on China and more... |
| 2013-05-27 00:15 | | China Biotech In Review: Hisun-Pfizer, Merck-Simcere JVs Come Into Focus and more... |
| 2013-05-26 00:15 | | Big Pharma Learned The Wrong Marketing Lesson and more... |
| 2013-05-25 00:15 | | Merck & Co Inc Stock Buy Recommendation Reiterated (MRK) and more... |
| 2013-05-24 12:15 | | Impax Launches Generic Zomig and more... |
| 2013-05-24 00:15 | | 3 Pipeline Obesity Treatments You Should Watch and more... |
| 2013-05-23 12:15 | | Regeneron Shareholders Watching Optina Trial Closely and more... |
| 2013-05-23 00:15 | | FDA panel favors Merck sleeping aid despite safety concerns over drowsiness, driving issues and more... |
| 2013-05-22 12:15 | | U.S. government taps GlaxoSmithKline for new antibiotics and more... |
| 2013-05-22 00:15 | | Royalty ups bid as Elan unveils acquisitions and more... |
| 2013-05-21 12:15 | | The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does and more... |
| 2013-05-21 00:15 | | Bristol Myers Squibb And The New Wave Of Cancer Drugs and more... |
| 2013-05-20 12:15 | | AstraZeneca: A Dividend Payer With An Attractive Growth Prospect and more... |
| 2013-05-19 12:15 | | AbbVie Investors, Watch This Management Change (video) and more... |
| 2013-05-19 00:15 | | Allergan Targets Strides, Agila Over Generic Eye Drops and more... |
| 2013-05-18 00:15 | | Novo Nordisk completes PhIII hemophilia trial with positive results and more... |
| 2013-05-17 12:15 | | Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy and more... |
| 2013-05-17 00:15 | | Halozyme rises on pancreatic cancer drug study and more... |
| 2013-05-16 12:15 | | With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What and more... |
| 2013-05-16 00:15 | | J&J Wins Expanded Approval of Simponi for Bowel Disease and more... |
| 2013-05-15 12:15 | | Actavis Said to Have Spurned $15 Billion Offer From Mylan and more... |
| 2013-05-15 00:15 | | 2 Biotech Companies With Strong Product Launches To Monitor and more... |
| 2013-05-14 12:15 | | A Culture Change? AbbVie R&D Chief To Retire and more... |
| 2013-05-14 00:15 | | Astellas forecasts big sales growth as prostate drug catches hold and more... |
| 2013-05-13 12:15 | | Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi and more... |
| 2013-05-12 12:15 | | Sequenom Meets on the Top Line, Misses Where it Counts and more... |
| 2013-05-12 00:15 | | BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results and more... |
| 2013-05-11 00:15 | | Actavis Said to Be in Early Talks to Acquire Warner Chilcott and more... |
| 2013-05-10 12:15 | | Second FDA thumbs-up for Novartis Ilaris and more... |
| 2013-05-10 00:15 | | Review Of Depomed First Quarter 2013 Results and more... |
| 2013-05-09 12:15 | | Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says and more... |
| 2013-05-09 00:15 | | Pacira Pharmaceuticals Increases Sales but Misses Estimates on Earnings and more... |
| 2013-05-08 12:15 | | China backs its booming biopharma industry with big subsidies and more... |
| 2013-05-08 00:15 | | Pfizer Online Viagra Sales: Big Shift Or No Big Deal? and more... |
| 2013-05-07 12:15 | | Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment and more... |
| 2013-05-06 12:15 | | FDA âÔö£é?öé??Ôö£éÔòª?úbreakthroughâÔö£é?öé??Ôö£é?ö?ñó tab on AbbVie Hepatitis C drug leaves shares flat and more... |
| 2013-05-05 12:15 | | Teva Pharmaceutical Industries Hits Estimates, But GAAP Results Lag Last Year's and more... |
| 2013-05-04 12:15 | | It's Pipeline That Matters Most and more... |
| 2013-05-04 00:15 | | Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial and more... |
| 2013-05-03 12:15 | | Teva Pharma 1st qtr profit sinks 27 percent as generic competition, other factors hurt revenue and more... |
| 2013-05-03 00:15 | | EPO Pills: A Challenge For Amgen And Johnson & Johnson and more... |
| 2013-05-02 12:15 | | Merck buddies up to Scripps spinout Abide in $430M diabetes partnership and more... |
| 2013-05-02 00:15 | | Allergan shares fall on delay of eye drug study and more... |
| 2013-05-01 12:15 | | Allergan Evaluates Bids for its Lap-Band Weight Loss Product and more... |
